Zytiga Extends Lives of Prostate Cancer Patients, Study Says

Zytiga, made by Johnson & Johnson (JNJ) unit Centocor Ortho Biotech, gave men with advanced prostate cancer an average of four months of extra life, according to Phase III trial results published in the New England Journal of Medicine

Source: http://feeds.foxnews.com/~r/foxnews/health/~3/6dGu0JFCGLQ/

cage computer processor anger profile